<DOC>
	<DOCNO>NCT02132936</DOCNO>
	<brief_summary>The purpose compare efficacy treatment LEO 90100 Week 4 calcipotriol plus betamethasone dipropionate ( BDP ) gel Week 8 subject psoriasis vulgaris</brief_summary>
	<brief_title>LEO 90100 Aerosol Foam Compared Calcipotriol Plus Betamethasone Dipropionate Gel Subjects With Psoriasis Vulgaris</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Betamethasone benzoate</mesh_term>
	<mesh_term>Betamethasone-17,21-dipropionate</mesh_term>
	<mesh_term>Betamethasone</mesh_term>
	<mesh_term>Betamethasone Valerate</mesh_term>
	<mesh_term>Betamethasone sodium phosphate</mesh_term>
	<mesh_term>Calcipotriene</mesh_term>
	<mesh_term>Calcitriol</mesh_term>
	<criteria>Age 18 year Psoriasis vulgaris trunk and/or limb ( exclude psoriasis genitals skin fold ) involve 230 % Body Surface Area ( BSA ) A Physician 's Global Assessment disease severity ( PGA ) least mild trunk limbs A modified Psoriasis Area Severity Index ( PASI ) score least 2 trunk limb . Current diagnosis guttate , erythrodermic , exfoliative pustular psoriasis Systemic treatment biological therapy , whether market , possible effect psoriasis vulgaris within follow time period prior randomisation : etanercept within 4 week prior randomisation adalimumab , infliximab within 8 week prior randomisation ustekinumab within 16 week prior randomisation product within 4 weeks/5 halflives prior randomisation ( whichever longer ) Systemic treatment therapy possible effect psoriasis vulgaris ( e.g . corticosteroid , retinoids , methotrexate , ciclosporin immunosuppressant within 4 week prior randomisation ) Subjects receive treatment nonmarketed drug substance ( i.e . drug yet make available clinical use follow registration ) within 4 weeks/5 halflives ( whichever longer ) prior randomisation . Psoralen combine Ultraviolet A ( PUVA ) therapy within 4 week prior randomisation Ultraviolet B ( UVB ) therapy within 2 week prior randomisation Topical antipsoriatic treatment trunk limb ( except emollient ) within 2 week prior randomisation Topical treatment face , scalp skin fold corticosteroid , vitamin D analogue prescription shampoo within 2 week prior randomisation Females pregnant , wish become pregnant trial breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>